These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 20363879)

  • 1. GLP-1(7-36)-amide and Exendin-4 stimulate the HPA axis in rodents and humans.
    Gil-Lozano M; Pérez-Tilve D; Alvarez-Crespo M; Martís A; Fernandez AM; Catalina PA; Gonzalez-Matias LC; Mallo F
    Endocrinology; 2010 Jun; 151(6):2629-40. PubMed ID: 20363879
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Corticotropin-releasing hormone and the sympathoadrenal system are major mediators in the effects of peripherally administered exendin-4 on the hypothalamic-pituitary-adrenal axis of male rats.
    Gil-Lozano M; Romaní-Pérez M; Outeiriño-Iglesias V; Vigo E; González-Matías LC; Brubaker PL; Mallo F
    Endocrinology; 2014 Jul; 155(7):2511-23. PubMed ID: 24731096
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of prolonged exendin-4 administration on hypothalamic-pituitary-adrenal axis activity and water balance.
    Gil-Lozano M; Romaní-Pérez M; Outeiriño-Iglesias V; Vigo E; Brubaker PL; González-Matías LC; Mallo F
    Am J Physiol Endocrinol Metab; 2013 May; 304(10):E1105-17. PubMed ID: 23531615
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prolonged exendin-4 administration stimulates pituitary-adrenocortical axis of normal and streptozotocin-induced diabetic rats.
    Malendowicz LK; Neri G; Nussdorfer GG; Nowak KW; Zyterska A; Ziolkowska A
    Int J Mol Med; 2003 Oct; 12(4):593-6. PubMed ID: 12964040
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of central glucagon-like peptide-1 in hypothalamo-pituitary-adrenocortical facilitation following chronic stress.
    Tauchi M; Zhang R; D'Alessio DA; Seeley RJ; Herman JP
    Exp Neurol; 2008 Apr; 210(2):458-66. PubMed ID: 18177641
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cocaine- and amphetamine-regulated transcript activates the hypothalamic-pituitary-adrenal axis through a corticotropin-releasing factor receptor-dependent mechanism.
    Smith SM; Vaughan JM; Donaldson CJ; Rivier J; Li C; Chen A; Vale WW
    Endocrinology; 2004 Nov; 145(11):5202-9. PubMed ID: 15271883
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exendin-4, a GLP-1 receptor agonist, stimulates pituitary-adrenocortical axis in the rat: Investigations into the mechanism(s) underlying Ex4 effect.
    Malendowicz LK; Nussdorfer GG; Nowak KW; Ziolkowska A; Tortorella C; Trejter M
    Int J Mol Med; 2003 Aug; 12(2):237-41. PubMed ID: 12851724
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The kappa-opioid receptor agonist MR-2034 stimulates the rat hypothalamic-pituitary-adrenal axis: studies in vivo and in vitro.
    Calogero AE; Scaccianoce S; Burrello N; Nicolai R; Muscolo LA; Kling MA; Angelucci L; D'Agata R
    J Neuroendocrinol; 1996 Aug; 8(8):579-85. PubMed ID: 8866244
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of subdiaphragmatic vagotomy on the noradrenergic and HPA axis activation induced by intraperitoneal interleukin-1 administration in rats.
    Wieczorek M; Dunn AJ
    Brain Res; 2006 Jul; 1101(1):73-84. PubMed ID: 16784727
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stressing diabetes? The hidden links between insulinotropic peptides and the HPA axis.
    Diz-Chaves Y; Gil-Lozano M; Toba L; Fandiño J; Ogando H; González-Matías LC; Mallo F
    J Endocrinol; 2016 Aug; 230(2):R77-94. PubMed ID: 27325244
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of treadmill exercise on hypoactivity of the hypothalamo-pituitary-adrenal axis induced by chronic administration of corticosterone in rats.
    Kim HG; Lim EY; Jung WR; Shin MK; Ann ES; Kim KL
    Neurosci Lett; 2008 Mar; 434(1):46-9. PubMed ID: 18276074
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exendin-4 potently decreases ghrelin levels in fasting rats.
    Pérez-Tilve D; González-Matías L; Alvarez-Crespo M; Leiras R; Tovar S; Diéguez C; Mallo F
    Diabetes; 2007 Jan; 56(1):143-51. PubMed ID: 17192476
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulatory mechanism of hypothalamo-pituitary-adrenal (HPA) axis and neuronal changes after adrenalectomy in type 2 diabetes.
    Yi SS; Hwang IK; Shin JH; Choi JH; Lee CH; Kim IY; Kim YN; Won MH; Park IS; Seong JK; Yoon YS
    J Chem Neuroanat; 2010 Oct; 40(2):130-9. PubMed ID: 20472052
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Direct evidence that stimulation of neuropeptide Y Y5 receptor activates hypothalamo-pituitary-adrenal axis in conscious rats via both corticotropin-releasing factor- and arginine vasopressin-dependent pathway.
    Kakui N; Kitamura K
    Endocrinology; 2007 Jun; 148(6):2854-62. PubMed ID: 17363455
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Free fatty acids activate the hypothalamic-pituitary-adrenocortical axis in rats.
    Widmaier EP; Rosen K; Abbott B
    Endocrinology; 1992 Nov; 131(5):2313-8. PubMed ID: 1330498
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differences in the central anorectic effects of glucagon-like peptide-1 and exendin-4 in rats.
    Barrera JG; D'Alessio DA; Drucker DJ; Woods SC; Seeley RJ
    Diabetes; 2009 Dec; 58(12):2820-7. PubMed ID: 19741167
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A new orally available glucagon-like peptide-1 receptor agonist, biotinylated exendin-4, displays improved hypoglycemic effects in db/db mice.
    Jin CH; Chae SY; Son S; Kim TH; Um KA; Youn YS; Lee S; Lee KC
    J Control Release; 2009 Feb; 133(3):172-7. PubMed ID: 18977255
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prostaglandins and interleukin-1beta in the hypothalamic-pituitary-adrenal response to systemic phenylephrine under basal and stress conditions.
    Gadek-Michalska A; Bugajski AJ; Bugajski J
    J Physiol Pharmacol; 2008 Sep; 59(3):563-75. PubMed ID: 18953098
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intracerebroventricular administration of corticotrophin-releasing hormone receptor antagonists produces different effects on hypothalamic pituitary adrenal responses to novel restraint depending on the stress history of the animal.
    Vining C; Iyer V; Bhatnagar S
    J Neuroendocrinol; 2007 Mar; 19(3):198-207. PubMed ID: 17280593
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel in vitro perfusion system for the determination of hypothalamic-pituitary-adrenal axis responses.
    Moidel MA; Belz EE; Czambel RK; Rubin RT; Rhodes ME
    J Pharmacol Toxicol Methods; 2006; 53(3):264-71. PubMed ID: 16311047
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.